Exagen (XGN) Receivables (2018 - 2026)

Exagen (XGN) has 9 years of Receivables data on file, last reported at $15.8 million in Q1 2026.

• Quarterly Receivables rose 7.48% year-over-year to $15.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (up 7.48% YoY) and the FY2025 annual result came in at $10.9 million, up 38.54% from the prior year.
• Receivables climbed to $15.8 million in Q1 2026, from $10.9 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $17.0 million in Q3 2023 to a low of $6.1 million in Q4 2022.
• A 5-year average of $11.3 million and a median of $10.9 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables surged 86.29% — and 2024, when it plunged 44.92%.
• Tracing XGN's Receivables over 5 years: stood at $6.1 million in 2022, then advanced by 8.2% to $6.6 million in 2023, then grew by 18.71% to $7.8 million in 2024, then surged by 38.54% to $10.9 million in 2025, then surged by 45.56% to $15.8 million in 2026.
• The last three Receivables figures came in at $15.8 million (Q1 2026), $10.9 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.